- Home
- MTEX vs TENX Comparison
MTEX vs TENX Comparison
Compare MTEX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- TENX
- Stock Information
- Founded
- MTEX 1993
- TENX 1967
- Country
- MTEX United States
- TENX United States
- Employees
- MTEX N/A
- TENX N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- TENX Health Care
- Exchange
- MTEX Nasdaq
- TENX Nasdaq
- Market Cap
- MTEX 19.9M
- TENX 21.6M
- IPO Year
- MTEX 1999
- TENX N/A
- Fundamental
- Price
- MTEX $10.00
- TENX $5.56
- Analyst Decision
- MTEX
- TENX Strong Buy
- Analyst Count
- MTEX 0
- TENX 3
- Target Price
- MTEX N/A
- TENX $16.00
- AVG Volume (30 Days)
- MTEX 1.7K
- TENX 13.0K
- Earning Date
- MTEX 05-20-2025
- TENX 05-20-2025
- Dividend Yield
- MTEX N/A
- TENX N/A
- EPS Growth
- MTEX N/A
- TENX N/A
- EPS
- MTEX 1.32
- TENX N/A
- Revenue
- MTEX $117,866,000.00
- TENX N/A
- Revenue This Year
- MTEX N/A
- TENX N/A
- Revenue Next Year
- MTEX N/A
- TENX N/A
- P/E Ratio
- MTEX $7.58
- TENX N/A
- Revenue Growth
- MTEX N/A
- TENX N/A
- 52 Week Low
- MTEX $6.75
- TENX $2.77
- 52 Week High
- MTEX $16.49
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- MTEX 49.29
- TENX 51.64
- Support Level
- MTEX $9.70
- TENX $5.49
- Resistance Level
- MTEX $11.90
- TENX $5.87
- Average True Range (ATR)
- MTEX 0.24
- TENX 0.33
- MACD
- MTEX -0.03
- TENX 0.04
- Stochastic Oscillator
- MTEX 24.00
- TENX 84.80
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.